Synvisc-One (hylan G-F 20, from Genzyme), has been FDAapproved for the relief of pain associated with osteoarthritis (OA) of the kneein patients who have failed to respond adequately to ...

Genzyme Corporation today announced that the FDA's Orthopaedic and Rehabilitation Devices Advisory Committee voted unanimously (5 - 0) in favor of approval without conditions of Synvisc-One TM (hylan ...

Feb. 6, 2003 (New Orleans) — In a head-to-head study comparing intra-articular hylan GF-20 injection (Synvisc) to corticosteroid injection for knee osteoarthritis, "there was no difference in outcome ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted marketing approval to Genzyme Corp. for its Synvisc-One product indicated for the relief of ...

Synvisc and Hyalgan are both brand-name drugs used in viscosupplementation to treat osteoarthritis knee pain by cushioning the joint and improving mobility. Both Synvisc and Hyalgan are made from ...

BOSTON, Feb 26 (Reuters) - Genzyme Corp said on Thursday it has won European approval to make its drug Myozyme at a 4,000-liter manufacturing facility, expanding supply for patients with the rare ...

To earn CME related to this news article, click here. March 5, 2009 — The US Food and Drug Administration (FDA) has approved budesonide plus formoterol fumarate dihydrate inhalation aerosol for the ...

Hylan G-F 20 (hylan A and hylan B) 48mg; per 6mL; soln for intra-articular inj. Avian protein, feathers, or egg allergy. Severely inflamed knee joints. Lymphatic or venous stasis in leg. Advise ...

What Are Hyalgan and Synvisc? Hyaluronic acid is a natural, gel-like substance in your joints. It cushions and lubricates your joints as you move them. If you develop OA, cartilage in your joint ...

"The submission for approval of Synvisc-One is based on positive data which demonstrated that combining three doses of Synvisc in a single treatment is safe and effective in providing pain relief for ...

Important Therapy Provides Six Months Pain Relief with Single Injection Genzyme Corporation (Nasdaq: GENZ) today announced that the U.S. Food and Drug Administration (FDA) has granted marketing ...